Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
29
-
Total 13F shares, excl. options
-
2,840,185
-
Shares change
-
+37,471
-
Total reported value, excl. options
-
$954,327
-
Value change
-
+$6,302
-
Put/Call ratio
-
5.6%
-
Number of buys
-
13
-
Number of sells
-
8
-
Price
-
$0.3360
Institutional Holders of IGC Pharma, Inc. - COM NEW (IGC) as of Q4 2024
As of 31 Dec 2024 IGC Pharma, Inc. - COM NEW (IGC) had 33 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 2,840,185 shares of stock of the company.
Largest 10 holders included BlackRock, Inc., GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, STATE STREET CORP, Squarepoint Ops LLC, NORTHERN TRUST CORP, DEARBORN PARTNERS LLC, GOLDMAN SACHS GROUP INC, TWO SIGMA SECURITIES, LLC, and TRUIST FINANCIAL CORP.
This table shows 33 institutional shareholders of the security as of 31 Dec 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.